The Global Ethylenediamine Diaceturate Market was valued at USD 125.4 Million in 2024 and is projected to reach USD 210.5 Million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.3% during the forecast period (2025–2032). This growth is driven by the rising global volume of surgical procedures, increasing demand for effective hemostatic agents in trauma care, and the expansion of healthcare infrastructure in emerging economies. While the market remains competitive with several alternative hemostatic technologies, ethylenediamine diaceturate continues to hold a critical position in clinical settings due to its efficacy in controlling bleeding.

As the healthcare sector increasingly focuses on improving patient outcomes and reducing surgical complications, the role of reliable hemostatic agents has become paramount. In this blog, we profile the Top 10 Companies in the Ethylenediamine Diaceturate Industry—a group of established pharmaceutical manufacturers and emerging players who are shaping the production and distribution of this vital medical compound.

---

🔟 1. Changchun Dazheng Pharmaceutical Co., Ltd.

Headquarters: Changchun, Jilin, China
Key Offering: Ethylenediamine Diaceturate API, Finished Dosage Forms

Changchun Dazheng is a dominant force in the ethylenediamine diaceturate market, recognized as a leading producer of the Active Pharmaceutical Ingredient (API). The company leverages vertically integrated manufacturing processes to ensure high purity and consistent quality, supplying both domestic Chinese markets and international clients. Their extensive experience in hemostatic agents has established them as a preferred partner for pharmaceutical companies worldwide.

Key Initiatives:

• Continuous process optimization for enhanced API yield and purity

• Strategic partnerships with domestic and international pharmaceutical distributors

• Investment in R&D for novel formulations and expanded therapeutic applications

Download FREE Sample Report:
Ethylenediamine Diaceturate Market – View in Detailed Research Report

---

9️⃣ 2. Jinzhou Jiutai Pharmaceutical Co., Ltd.

Headquarters: Jinzhou, Liaoning, China
Key Offering: Ethylenediamine Diaceturate Powder and Injections

Jinzhou Jiutai is a major manufacturer with a significant footprint in the Asian pharmaceutical market. The company specializes in the production of ethylenediamine diaceturate in various forms, including high-purity powder for formulation and ready-to-use injectable solutions. Their robust quality control systems comply with international standards, making them a key supplier for hospital pharmacies and contract manufacturers.

Key Initiatives:

• Expansion of GMP-certified production facilities to increase capacity

• Focus on cost-effective manufacturing to serve price-sensitive markets

---

8️⃣ 3. Jinan Welcome Pharmaceutical Co., Ltd.

Headquarters: Jinan, Shandong, China
Key Offering: Ethylenediamine Diaceturate API and Custom Synthesis

Jinan Welcome Pharmaceutical has carved a niche as a reliable supplier of pharmaceutical intermediates and APIs, including ethylenediamine diaceturate. The company is known for its strong R&D capabilities and flexibility in catering to custom synthesis requirements for clients seeking specific grades or formulations of the compound.

Key Initiatives:

• Development of high-purity grades for specialized medical applications

• Strengthening of export channels to Europe and Southeast Asia

---

7️⃣ 4. Jian Yisheng Pharmaceutical Co., Ltd.

Headquarters: Shijiazhuang, Hebei, China
Key Offering: Ethylenediamine Diaceturate for Gynecological and Surgical Use

Jian Yisheng focuses on developing and manufacturing hemostatic drugs, with ethylenediamine diaceturate being a core product in their portfolio. The company has invested significantly in clinical research to validate the efficacy of its products in specific applications, such as controlling obstetrical and gynecological hemorrhage, which are high-growth segments within the market.

Key Initiatives:

• Targeted R&D for applications in obstetrics and minimally invasive surgery

• Recent capital investment of approximately $15 million to expand dedicated production lines

Download FREE Sample Report:
Ethylenediamine Diaceturate Market – View in Detailed Research Report

---

6️⃣ 5. Nanjing Joyfulchem Co., Ltd.

Headquarters: Nanjing, Jiangsu, China
Key Offering: Pharmaceutical Intermediates and Ethylenediamine Diaceturate

Nanjing Joyfulchem operates as a specialist chemical supplier providing high-quality intermediates to the pharmaceutical industry. Their ethylenediamine diaceturate is known for its consistency and is supplied to formulation companies that produce finished hemostatic drugs for hospitals and clinics.

Key Initiatives:

• Emphasis on supply chain reliability and consistent product quality

• Building long-term partnerships with formulation manufacturers

---

5️⃣ 6. Hubei Widely Chemical Technology Co., Ltd.

Headquarters: Wuhan, Hubei, China
Key Offering: Fine Chemicals and Ethylenediamine Diaceturate

Hubei Widely Chemical is a technology-driven company that produces a range of fine chemicals, including ethylenediamine diaceturate for pharmaceutical use. They utilize advanced synthesis and purification technologies to meet the stringent requirements of the medical sector.

Key Initiatives:

• Investment in green chemistry principles for sustainable manufacturing

• Development of proprietary purification techniques

---

4️⃣ 7. Zhejiang Kangle Pharmaceutical Co., Ltd.

Headquarters: Taizhou, Zhejiang, China
Key Offering: Finished Dosage Forms containing Ethylenediamine Diaceturate

Zhejiang Kangle is primarily a finished dosage formulation company that integrates backward into API production. They market ethylenediamine diaceturate under their own brand names, offering injectables and other forms directly to healthcare providers, which gives them greater control over the supply chain and market presence.

Key Initiatives:

• Vertical integration from API to finished product manufacturing

• Brand building and marketing directly to end-user hospitals

---

3️⃣ 8. Shanghai Yuliang Industrial Co., Ltd.

Headquarters: Shanghai, China
Key Offering: Chemical Exports including Ethylenediamine Diaceturate

Shanghai Yuliang Industrial functions as a key exporter of pharmaceutical chemicals from China. The company sources ethylenediamine diaceturate from qualified manufacturers and distributes it to global markets, leveraging its established international logistics and regulatory compliance expertise.

Key Initiatives:

• Managing complex international supply chains and customs logistics

• Ensuring products meet the regulatory standards of various import countries

---

2️⃣ 9. Beijing Yibai Biotechnology Co., Ltd.

Headquarters: Beijing, China
Key Offering: High-Purity Biochemicals for Medical Research and Pharma

Beijing Yibai Biotechnology caters to both the research and commercial pharmaceutical sectors. They supply high-purity ethylenediamine diaceturate that is used not only in drug manufacturing but also in academic and clinical research aimed at discovering new applications for the compound.

Key Initiatives:

• Serving the niche market of research-grade biochemicals

• Collaboration with academic institutions on therapeutic research

---

1️⃣ 10. Other Regional and Emerging Manufacturers

Headquarters: Various locations across Asia and Europe
Key Offering: Localized production and supply of Ethylenediamine Diaceturate

This segment includes a collection of smaller, regional manufacturers and new entrants aiming to capture local market share. These companies often focus on specific regional regulations, cost-effective production for local hospitals, or developing novel delivery systems for ethylenediamine diaceturate to differentiate themselves.

Key Initiatives:

• Addressing regional supply gaps and reducing import dependency

• Innovating in formulation technology for improved ease of use

Get Full Report Here:
Ethylenediamine Diaceturate Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Hemostatic Agents is More Precise and Accessible

The ethylenediamine diaceturate market is evolving in response to broader trends in healthcare. While it remains a cornerstone for bleeding control, the industry is investing in research to enhance its efficacy, expand its applications, and improve its accessibility worldwide.

📈 Key Trends Shaping the Market:

• R&D into advanced formulations for faster hemostasis and reduced side effects

• Growing adoption in minimally invasive surgical procedures requiring precise bleeding control

• Expansion of production capacity in Asia-Pacific to meet global demand growth

• Increasing integration of hemostatic agents into standardized surgical protocols

Get Full Report Here:
Ethylenediamine Diaceturate Market – View in Detailed Research Report

The companies listed above are not only supplying a critical medical compound—they are contributing to the advancement of surgical safety and patient care on a global scale.